FDA Notice of Detention Archives - Customs & International Trade Law Firm https://diaztradelaw.com/category/fda/fda-notice-of-detention/ Jennifer Diaz Thu, 07 Jul 2022 16:14:53 +0000 en-US hourly 1 https://i0.wp.com/diaztradelaw.com/wp-content/uploads/2017/06/ms-icon-310x310.png?fit=32%2C32&ssl=1 FDA Notice of Detention Archives - Customs & International Trade Law Firm https://diaztradelaw.com/category/fda/fda-notice-of-detention/ 32 32 200988546 HELP! CBP Seized My Tobacco Products as Drug Paraphernalia, What Now? https://diaztradelaw.com/help-cbp-seized-my-tobacco-products-as-drug-paraphernalia-what-now/ https://diaztradelaw.com/help-cbp-seized-my-tobacco-products-as-drug-paraphernalia-what-now/#respond Tue, 30 May 2017 10:20:24 +0000 https://diaztradelaw.com/?p=2962 Our office has increasingly received requests for guidance on importation of marijuana paraphernalia products to the U.S. where twenty-six (26) states have legalized the use of marijuana for medical purposes and/or personal consumption such as California, Massachusetts, Maine and Nevada. The purpose of this article is to dispel the confusion as to why paraphernalia products (grinders, storage containers, rolling paper, pipes, vape pens, etc.) are continuously being seized by U.S. Customs and Border Protection (CBP), even when such products may be used by tobacco smokers. It is important to address the realities between federal and state laws regulating drug paraphernalia products so importers can avoid CBP’s enforcement of U.S. Laws.

Why Does CBP Stop Drug Paraphernalia?

  • CBP secures America’s borders at and between ports of entry by stopping inadmissible people and illicit goods. The Tariff Act of 1789 provides one of CBP’s core functions: to act as the leading federal agency in determining the admissibility of goods that may enter the Commerce of the United States. Even though each State has internally legalized marijuana either for medical or recreational purposes, CBP still has the express power to authorize or not any merchandise that comes into the U.S. Thus, CBP can detain and seize “drug paraphernalia” even if you did not intend to use the product that purpose pursuant to 19 U.S.C. § 1595a(c) stating a violation of 21 U.S.C. § 863.

What Constitutes Drug Paraphernalia?

In 2014, a smoke shop owner imported different merchandise from China described as “glass hookahs and parts”. The Central District of California considered these products, which were valued at $82,933.64 as drug paraphernalia and thus detained and seized the merchandise pursuant to 19 U.S.C. § 1595a(c) for violations of 21 U.S.C. § 863. The U.S. sued the shop owner and the Court concluded that “despite…[the] erroneous characterization of the merchandise as ‘hookah pipes’…they are bongs, and are therefore barred from entry into the United States.”

To determine whether the product is drug paraphernalia, the Court will not only consider the Code, but also other relevant factors such as the existence and scope of legitimate uses of the product in the community and expert testimony concerning its use. Under 21 U.S.C. Section 863(e), the following items are used to determine if a product is drug paraphernalia:

(1) instructions, oral or written, provided with the item concerning its use;

(2) descriptive materials accompanying the item which explain or depict its use;

(3) national and local advertising concerning its use;

(4) the manner in which the item is displayed for sale;

(5) whether the owner, or anyone in control of the item, is a legitimate supplier of like or related items to the community, such as a licensed distributor or dealer of tobacco products;

(6) direct or circumstantial evidence of the ratio of sales of the item(s) to the total sales of the business enterprise;

(7) the existence and scope of legitimate uses of the item in the community; and

(8) expert testimony concerning its use.

There is no requirement that the violator had specific knowledge that the merchandise constituted drug paraphernalia. United States v. 160 Cartons of Glass Water Pipes, Case No. CV 12-8965- BRO (VBKx) (C.D. Cal. Mar.  10, 2014).

What Must You Refrain From Doing?

  • Sell or offer to sell drug paraphernalia
  • Mail drug paraphernalia or transport it through interstate commerce
  • Import or Export drug paraphernalia

REMEMBER: CBP is the federal agency that has control over everything that is imported and exported to/from the U.S. and therefore, they have the power to detain and seize your products when it constitutes drug paraphernalia. This will continue to happen until Congress decides to enact a Federal Law that allows marijuana consumption on a federal level or drug paraphernalia within the U.S.

What Do You Do if CBP Detains and/or Seizes Your Merchandise?

CBP has the power to detain persons or merchandise and make admissibility decisions. If CBP believes merchandise should be detained, it is required to send a Notice of Detention no later than five (5) business days from the day of examination. Often, the Notice of Detention does not specify the circumstances of the detention or is not even issued. It is important during this detention phase to communicate with CBP to discuss why your merchandise should not constitute drug paraphernalia and should be released.

CBP also has the ability to seize your merchandise if it is contrary to law and CBP will send a Seizure Notice, which you will have 30 days to respond, and typically we respond in the form of a Petition. Seizure cases are complicated, it is best to hire an expert who knows the policies, internal procedures and practices of U.S. Customs. Most importantly, getting involved early in the detention process is the best way to tackle this issue.

Want to Know if Your Product Will be Considered Drug Paraphernalia Prior to Importing?

Prior to importing your product, we recommend you review your product with an expert and determine whether to request a Binding Ruling from CBP. In CBP Ruling HQ H150766, an importer inquired on whether its hookah and hookah components constituted drug paraphernalia. The major issue CBP decided was whether the hookahs are “primarily intended” for use with drugs since it is considered a multiple-use item. CBP ruled that hookahs are admissible merchandise into the United States and held that they are not considered drug paraphernalia based on the weight of the evidence addressing the 8 criteria as set forth in 21 U.S.C. § 863, specifically its intended use for tobacco and not drugs.

If you have questions on whether or not your product constitutes drug paraphernalia and are interested in requesting a binding ruling, or if CBP has detained or seized your product, contact our office at info@diaztradelaw.com or (305) 456-3830 for assistance.

]]>
https://diaztradelaw.com/help-cbp-seized-my-tobacco-products-as-drug-paraphernalia-what-now/feed/ 0 2962
Here’s a Recap of Part II of our #WorldTradeMonth Seminar Series for Compliance Professionals on FDA FSMA and FSVP https://diaztradelaw.com/heres-a-recap-of-part-ii-of-our-worldtrademonth-seminar-series-for-compliance-professionals-on-fda-fsma-and-fsvp/ https://diaztradelaw.com/heres-a-recap-of-part-ii-of-our-worldtrademonth-seminar-series-for-compliance-professionals-on-fda-fsma-and-fsvp/#respond Fri, 19 May 2017 14:47:43 +0000 https://diaztradelaw.com/?p=2960 Yesterday, we at DTL, had the pleasure of hosting Part II of our #WorldTradeMonth Seminar Series for Compliance Professionals. The second seminar focused on FDA FSMA (Food Safety Modernization Act) Compliance for Importers with expert speakers from the U.S. Food and Drug Administration (FDA) and industry. We had a packed house with an array of attendees such as importers of food, beverages, and medical devices, along with customs brokers, freight forwarders / NVOCCs, lawyers, consultants, and others. We received requests for a re-cap from those who attended and industry members who were not able to attend. You asked and we deliver. Here is our recap:

The morning kicked off with a networking breakfast where experienced and novice industry members were able to engage in meaningful dialogue about overlapping issues they experience in their respective workplaces in dealing with the topic of FSMA. We heard comments from small to large business on their current implementation strategies in place to ensure they meet FSMA requirements by FDA’s compliance dates.

The seminar promptly began at 9:00 am with introductory remarks by our own President, Jennifer Diaz. We had all attendees introduce themselves and include why this seminar was important to attend. We were glad to hear from majority of attendees that their reason for participating was to further their education on FSMA. One attendee commented, “Excited to hear from FDA about FSVP requirements and what the broker’s role is in the process.”

Next Representatives of Miami Free Zone explained their role in international business solutions as it provides users and visitors with convenient international business resources including turnkey FTZ solutions for distribution; a wholesale marketplace; an international business center environment; and premium showroom, office, and warehouse spaces. As well as providing FTZ users with flexible control over their domestic and foreign inventory, duty elimination and deferment, and high security standards for their businesses and valuable merchandise.

The first speaker was Elena O. Asturias, is a licensed U.S. Customs Broker, and Certified Customs Specialist providing customs brokerage services for imports. Elena provided top tips for custom brokers as she has been involved in logistics for over fifteen years, and has experience handling a broad range of commodities. Some helpful tips from here presentation include:

  • Make sure food facilities that must be registered with the FDA pursuant to the Bioterrorism act are registered to avoid delays upon entry into the U.S.
  • A major issue causing FDA to detain food products are product labeling violations
  • Ensure you use correct Affirmation of Compliance (AofC) Codes
    • When the entry is filed with FDA, use AofC codes to affirm the products meets specific import requirements.
    • Depending on the product type, many AofC’s are required, and must be submitted upon time of entry.
    • The AofC is a 3 letter indicator, then the qualifier which will vary in format. In some cases no qualifier is required.
  • FSVP – Unique facility identifier (UFI)
    • As of May 30th, you will need to add the UFI (Unique Facility Identifier) when you transmit the entry.
    • The AofC code being added is FSV, which will require the following:
      • DUNS number (as acceptable UFI)
      • Importer name & address
      • Email address
      • If the importer doesn’t have a DUNS number yet, you can transmit UNK “unknown” temporarily.
    • ENTRY DATA TRANSMISSION PROCESS:
    •  How Ace Works

Lundy Patrick followed Mrs. Asturias’ presentation and echoed the significance of being familiar with the importation process. Mr. Patrick is Lieutenant Commander serves as a U.S. Public Health Officer assigned to the Florida District Office of the FDA as an Imports Compliance Officer.  There were questions and answers during his presentation as the attendees had submitted questions prior to the seminar.  Here are highlights from the discussion:

  • Articles are expected to be in compliance AT THE TIME OF ENTRY. Therefore, you need to exercise due diligence to make sure the products you intend to import are in compliance PRIOR to the importation of the goods.
  • The following food imports require Prior Notice:
    • Food imported for use, storage, or distribution in the U.S. (including gifts and trade and quality assurance/quality control and market research samples)
    • Food transshipped through the U.S. to another country
    • Food imported for future export, or food for use in a Foreign Trade Zone, unless it is on the list of exemptions
  • If you fail to provide Prior Notice, the food shipment is subject to refusal and, if refused, must be held at the port of entry unless directed to another location. The importing or offering for import into the U.S. of an article of food in violation of Prior Notice requirements is a “Prohibited Act” under the laws FDA administers.
  • If a food product is assigned for examination/sampling, FDA will examine and will collect samples. Historically between 1-2% get examined/sampled.
  • Lieutenant Commander Patrick echoed the importance of product label compliance and stressed FDA does not pre-approve labels for food products.
  • He stated that the State of Florida, the third busiest district, has had over 8,000+ detention and 2200+ Refusals and provided the top reasons for food product detentions:
    • Labeling Issues:
      • Incorrect or missing statement of identity/name of the food
      • Failure to List potential allergens
      • Failure to declare ingredients
      • Failure to bear nutrition labeling or the nutrition label is in incorrect format.
    • Most common Import Alerts the FDA sees in Florida:
      • IA 16-81 – “Detention Without Physical Examination of Seafood Products Due to the Presence of Salmonella“
      • IA 99-05 – “Detention Without Physical Examination Of Raw Agricultural Products for Pesticides”
    • If Refused Goods are sold and Cannot be Redelivered for Export / Destruction, you may face:
      • Liquidated Damages and/or 19 USC 1592 Penalties

Thereafter, Giselle Jordan took the floor to discuss the hot topic of FSMA Compliance and Foreign Supplier Verification Program. Giselle is a Consumer Safety Officer at the Division of Import Operations of FDA. In August 2016, she joined the newly established Food Safety Verification Program Team. Here are highlights from her presentation:

  • Resources:
  • FSMA Sec. 301 requires importers to have FSVPs and FDA to issue regulations.
    • The goal for FSMA is FOOD SAFETY
  • Key Principles of FSVP Rule
    • Establishes explicit responsibility for importers to ensure the safety of imported food
    • Risk-based (according to types of hazards, importers, and suppliers)
    • Alignment with PC supply-chain provisions
    • Flexibility in meeting requirements (assessing activities conducted by others)
  • Purpose of an FSVP
    • To provide adequate assurances that:
      • Foreign suppliers produce food using processes and procedures providing same level of public health protection as FSMA preventive controls or produce safety provisions
      • Food is not adulterated or misbranded (as it relates to allergen labeling)
    • Who Must Comply?
      • “Importer” is U.S. owner or consignee of a food at time of U.S. entry.
      • If no U.S. owner or consignee at entry, importer is U.S. agent or representative of the foreign owner or consignee, as confirmed in signed statement of consent to serve as the importer under FSVP (“FSVP Importer”).
      • Note that the responsibility for FSVP compliance lies with the FSVP Importer and the FSVP Importer can be different from the Importer of Record.
    • FSVP Exemptions
      • Firms subject to juice or seafood HACCP regulations
      • Food for research or evaluation
      • Food for personal consumption
      • Alcoholic beverages and alcoholic beverage ingredients (7%)
      • Food transshipped through U.S.
      • Food imported for processing and export
      • “U.S. foods returned”
      • Meat, poultry, and egg products subject to USDA regulation at time of importation
      • Low acid canned food facilities (microbiological hazards only)
    • Appropriate Verification Activities
      • Must document determination, performance, conduct, review and assessment of results
      • Verification activities include:
      • Onsite audits (qualified auditor), sampling and testing of the food, a review of foreign supplier relevant food safety records, other appropriate activities
    • To qualify as a “Very Small Importer”:
      • Must meet definition of a very small importer
      • Less than $1 million/yr. in human food sales
      • Less than $2.5 million/yr. in animal food sales
      • Annually documentation of eligibility
    • Compliance Dates

Jennifer Diaz concluded the seminar with best practices for due diligence and best practices for responding to enforcement actions and FDA Notice of Action. Check out DTL’s TOP 10 TIPS for importing food products into the U.S.

For more information on how we can help you through the maze of importing and FSVP email us at info@diaztradelaw.com.

A special thanks to all our prize winner for participating during the seminar. We appreciate your involvement and interest! For pictures of the event LIKE us on Facebook.

Subscribe Today to keep up with the latest Customs and International Trade Law News.

Our next Live Broadcast webinar will be held on Wednesday, May 24, 2017 to discuss Intellectual Property Rights Violations and the U.S. Customs & Border Protections Enforcement. More information is available here.

DTL will also be at the NEI will be hosting the 3rd annual Global Trade Educational Conference held on August 7-8. NEI is bringing customs brokers, freight forwarders, NVOCCs, OTI, service providers, importers, exporters and all global logistics professionals an opportunity to update themselves on industry developments and connect with colleagues old and new. To RSVP – Read more. . .

*****This document is provided for informational purposes only and does not constitute legal advice nor does use of this constitute the formation of an attorney-client relationship.******

]]>
https://diaztradelaw.com/heres-a-recap-of-part-ii-of-our-worldtrademonth-seminar-series-for-compliance-professionals-on-fda-fsma-and-fsvp/feed/ 0 2960
World Trade Month Seminar Series for Compliance Professionals https://diaztradelaw.com/world-trade-month-seminar-series-for-compliance-professionals/ https://diaztradelaw.com/world-trade-month-seminar-series-for-compliance-professionals/#respond Thu, 20 Apr 2017 17:02:01 +0000 https://diaztradelaw.com/?p=2927 WORLD TRADE MONTH Seminar Series FlyerIn celebration of World Trade Month, Diaz Trade Law is hosting a World Trade Month Seminar Series for Compliance Professionals featuring U.S. Customs and Border Protection (CBP) and U.S. Food and Drug Administration (FDA) speakers.

In the first seminar, attendees will learn the ABC’s of Antidumping & Countervailing Duties (AD/CVD) compliance and CBP Enforcement.

In the second seminar, FDA will focus on food importations and discuss the upcoming Foreign Supplier Verification Program (FSVP) requirement under the Food Safety Modernization Act (FSMA).

The TOP reasons you should attend? 

  1. For a limited time, registration is FREE!
  2. You have the ability to hear DIRECTLY from CBP and FDA.
  3. We want the seminars to be informative and all of your questions answered. In that vain, we are currently taking ANY questions you have related to the Centers of Excellence and Expertise (CEE) and Antidumping & Countervailing Duties (AD/CVD) for CBP, and food importation/FSMA related questions for the FDA. Please email your questions today to info@diaztradelaw.com!

Full details including registration information for BOTH seminars are below. 

May 10, 2017 ( 9 – 11 a.m.)

  • ABC’s of AD/CVD & CBP Enforcement
  • CLICK HERE for our draft agenda
    • Hear directly from CBP Import Specialists & an industry legal expert
    • TOP Tips when Importing to Ensure Compliance with AD/CVD
    • Valuable opportunity to speak direct with Supervisory Import Specialist with U.S. Customs and Border Protection and legal experts to address any concerns relating to CBP’s role in administering and enforcing imports subject to AD/CVD
    • *** CBP WOULD LIKE TO HEAR FROM ATTENDEES OF THE TRADE COMMUNITY ON WHAT ISSUES OR QUESTIONS THEY WOULD LIKE TO BE ADDRESSED DURING THE PRESENTATION. PLEASE SUBMIT QUESTIONS TO INFO@DIAZTRADELAW.COM ***
  • RSVP HERE

May 18, 2017 ( 9 – 1 2 p.m.)

  • FDA FSMA Compliance Seminar for Importers
  • CLICK HERE for our draft agenda
    • Hear directly from FDA & an industry legal expert
    • Overview of FDA requirements for importing food products
    • A discussion of best practices when working with your broker to expedite shipments (ACE, ITACS, PREDICT)
    • Overview of the FSMA, including an overview of the FSVP requirement (which has a compliance date of 5/30/17)
    • Best practices for due diligence and responding to enforcement actions and FDA Notices of Action
    • *** FDA WOULD LIKE TO HEAR FROM ATTENDEES OF THE TRADE COMMUNITY ON WHAT ISSUES OR QUESTIONS THEY WOULD LIKE TO BE ADDRESSED DURING THE PRESENTATION. PLEASE SUBMIT QUESTIONS TO INFO@DIAZTRADELAW.COM ***
  • RSVP HERE 

We look forward to seeing you at our World Trade Month events!

]]>
https://diaztradelaw.com/world-trade-month-seminar-series-for-compliance-professionals/feed/ 0 2927
Register Now to Meet FDA’s Director of Import Operations and Maintenance – November 12, 2015 https://diaztradelaw.com/register-now-to-meet-fdas-director-of-import-operations-and-maintenance-november-12-2015/ https://diaztradelaw.com/register-now-to-meet-fdas-director-of-import-operations-and-maintenance-november-12-2015/#respond Fri, 06 Nov 2015 23:24:00 +0000
Do you need to know the current issues affecting importing and exporting for international trade professionals?  What about common compliance issues when importing food, cosmetics, and medical devices?  If you answered yes, you will not want to miss the last of our three-part seminar series that will cover these topics and much more.  Plus, members of supporting organizations, clients of Becker & Poliakoff, and future members and clients, will receive a discount!  Here’s all the information about our upcoming seminar:

Miami Free Zone
2305 N.W. 107th Avenue
Conference Room, 2M10, Miami, Florida 33172
  • This is a must attend seminar featuring FDA’s Director of Import Operations and Maintenance, Becker & Poliakoff’s Chair of the Customs and Trade Department, and an expert Customs Broker. Learn the best practices for handling FDA entries and compliance at this practical and informative seminar from the best.  
  • Hot Topics Covered will be: 
    • Resources for new and experienced importers
    • Use of free trade zones, including the Miami Free Zone
    •  How to work best with a customs broker to expedite your shipments
    • Top Reasons FDA Detains Goods (and specifics for Port of Miami!!) 
    • Food, Cosmetic, and Medical device basics, FDA laws/regulations
    • What you need to know about the FDA Import Process
    • Best practices for due diligence and responding to enforcement actions and FDA Notices of Action
Click Here to Register (Use Promotional Code “trade2015” for a Limited Time)
Please feel free to contact me at jdiaz@bplegal.com with any questions.  See you there!

]]>
https://diaztradelaw.com/register-now-to-meet-fdas-director-of-import-operations-and-maintenance-november-12-2015/feed/ 0 2235
Calling Medical Device Importers Attending U.S.’s TOP Medical Show, FIME https://diaztradelaw.com/calling-medical-device-importers-attending-u-s-s-top-medical-show-fime-2/ https://diaztradelaw.com/calling-medical-device-importers-attending-u-s-s-top-medical-show-fime-2/#respond Wed, 29 Jul 2015 23:38:00 +0000

If you import medical devices into the U.S. (or want to), FIME is the trade show for you.  Last year, FIME surveyed attendees and received feedback that 52,890 FIME attendees were interested in 25 categories of medical device products. FIME is the #1 Medical Show, and the #1 Medical Trade Fair – and takes place from August 5-7, in my home town, at the Miami Beach Convention CenterSince 2010, I have had the privilege to be a speaker at FIME and had some of the largest groups of attendees to discuss compliance with the FDA, and how to resolve typical FDA and CBP issues.  
I’m thrilled to say I’m speaking again this year. My topic is “How to Effectively Resolve Typical U.S.Food and Drug Administration (FDA) and U.S. Customs and Border Protection (CBP) Issues for Medical Devices”.

My seminar will take place on August 5, 2015, at 10:00 am (EST) in Room D232.

To entice you to attend, here’s a snapshot of the agenda:

  • Medical Device Basics
  • FDA Laws/Regulations
  • FDA Import Process
  • What You Need to Know to Import
  • How to Work Best to Expedite Your Shipments with a Customs Broker
  • FDA Notices of Action 
  • FDA Detention and Refusal Process
  • Import Alerts
  • Detention Without Physical Examination
  • Typical U.S. Customs Liquidated Damages and Seizure Process

Check out all of the terrific seminars here.

After attending this seminar, you will know how to effectively operate your business with a new understanding of how to effectively resolve the “worst case scenarios.”  We will discuss how we handle everyday examples of difficult issues with both the U.S. Food and Drug Administration (FDA) and U.S. Customs and Border Protection (CBP).  FDA issues include what to do if you receive a “Notice of FDA Action” stating that a medical device is adulterated or misbranded and will be refused admission into the United States, or a “Warning Letter” that could potential state you must stop producing certain medical devices because they are adulterated or misbranded.   Effectively resolving CBP issues includes the appropriate response when CBP says your goods are under “detention,” will be “seized” and “forfeited” or are included in the “detention without physical examination” list and how your company can get off the list.  You will also learn the appropriate response after you receive a “liquidated damages claim” up to $50,000 from CBP.  
Ready to Register? CLICK HERE, and REGISTER TODAY! 
If you will be at FIME, I am offering FREE consultations, at FIME ONLY. Contact me at jdiaz@bplegal.com to set up your FREE (no obligation) consultation today!
See you at FIME! 

]]>
https://diaztradelaw.com/calling-medical-device-importers-attending-u-s-s-top-medical-show-fime-2/feed/ 0 2240
IS YOUR COSMETIC PRODUCT REALLY A DRUG? https://diaztradelaw.com/is-your-cosmetic-product-really-a-drug-2/ https://diaztradelaw.com/is-your-cosmetic-product-really-a-drug-2/#respond Tue, 21 Jul 2015 22:48:00 +0000

In Junealone, the U.S. Food and Drug Administration (FDA) refused the importation of over 200 different shipments of Cosmetics from 22 different countries.

The two main reasons the FDA cited in refusing entry of cosmetic products were:

  1. The products were “misbranded” (lack of adequate directions for use, nutrient content and/or health claims, anti-ageing labeling claims rendering the product a drug; or
  2. The products were “adulterated” (unsafe addition of a color additive).
Definition of a Cosmetic vs. Drug
Misbranding may come down to whether the FDA believes the product is a drug (which is often based on the products intended use, and labeling claims). It is therefore important to know the difference in the way FDA defines cosmetics and drug products, to ensure you label your products correctly.
A product designed for “cleansing beautifying, promoting attractiveness, or altering the appearance,” is generally defined as a cosmeticby the FDA.
A drugon the other hand, is as a product “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease,” or “intended to affect the structure or any function of the body.”
Why Cosmetic Products will be Refused by the FDA
One prevalent reason the FDA refuses cosmetic products is because of the claims cosmetic products makes rendering the product a “drug”. A health claim is one example of a type of claim, specifically it is a claim that the product affects the structure and or function of the human body. If your product makes a health claim it may be rendered and regulated as a drug by the FDA.
In response to the increase use of “health claims” on cosmetic products, the FDA re-published an import alertfor skin care products labeled as anti-aging. These products claimed to reverse the effects of aging by controlling or preventing the aging process, which is a claim that the product affects the structure and functions of the human body, and were thus regulated a drug product by the FDA.
The FDA issued a consumer update this March highlighting the difference between a drug and a cosmetic product. The purpose of this publication was to inform consumers about cosmetic products that promise too much. In order to protect consumers from this type of cosmetic misbranding, the FDA has told companies to remove drugs claims or seek FDA approval to market these products as drugs (this is a timely and very expensive process). However, the FDA further admits that there is “no one-size-fits all answer” to whether a claim is a drug claim or cosmetic claim.
Form 766
If your product is on hold by the FDA because it is misbranded, there are affirmative actions you can take. Section 801(b) of the Federal Food, Drug, and Cosmetic Act states that an importer of record may submit to the FDA a written application (using FDA’s Form 766) requesting permission to “recondition” your product. This post-compliance action, if approved by the FDA, will allow your product to be released. As approval is discretionaryby the FDA, it is important you take the right steps and hire the right expert to assist you in this process.
FTC
In addition to regulation by the FDA, cosmetic companies are also subject to regulation by the Federal Trade Commission (FTC).  The FTC issues administrative complaints when companies engage in unfair methods of competition or unfair and deceptive acts, such as deceptive advertising. The FTC has issued complaints following FDA warning letters to cosmetic companies.
You may recall cosmetics company L’Oréal USA, Inc. receiving a FTC complaint alleging deceptive advertisingof its products Lancôme Génifique and L’Oréal Paris Youth Code. The FTC has accepted, subject to final approval, an agreement containing a consent order (proposed order) from L’Oréal. According to the complaint, L’Oréal violated Sections 5(a) and 12 of the Federal Trade Commission Act because they claimed that its Génifique products were “clinically proven” to “boost genes’ activity and stimulate the production of youth proteins that would cause “visibly younger skin in just 7 days,” and would make you look as if you “slept 2 extra hours.” Similarly, L’Oréal claimed that its Youth Code products were the “new era of skincare: gene science,” and that consumers could “crack the code to younger acting skin.” L’Oréal made these claims via print, radio, television, internet and social media outlets. (It is important to note, both FDA and FTC regulate not only the product, but, also all ancillary advertisements, including websites).
The FTC’s complaint followed the U.S. Food and Drug Administration’s (FDA) warningto L’Oreal about language used in their advertisements that made the products sound more like drugs than cosmetics.
How Diaz Trade Law Can Help
Although the FDA has issued import alerts, consumer updates, and labeling guides for cosmetics, there is still no bright line between cosmetic type claims and drug claims. Unfortunately, if the FDA finds your cosmetic product on the wrong side of that line, your product may be detained and later potentially refused by the FDA. The solution is to ensureyou use “pre-compliance”, by having all products, ingredients, claims and ancillary marketing reviewed by an expert PRIOR to importation.
]]>
https://diaztradelaw.com/is-your-cosmetic-product-really-a-drug-2/feed/ 0 2241
FDA Discusses TOP Reasons for Detention of Goods https://diaztradelaw.com/fda-discusses-top-reasons-for-detention-of-goods-2/ https://diaztradelaw.com/fda-discusses-top-reasons-for-detention-of-goods-2/#comments Thu, 21 Mar 2013 00:56:00 +0000 https://diaztradelaw.com/fda-discusses-top-reasons-for-detention-of-goods-2/ At today’s Import Operations Training, sponsored by the U.S. Food and Drug Administration (FDA) and the Florida Customs Brokers and Forwarders Association (FCBF), top officials from FDA traveled to Miami to educate importers and brokers. Topics ranged from a general overview of FDA compliance, TOP rationales for FDA detentions, Food Safety and Modernization Act (FSMA) updates, an overview of the newly re-organized (now DIO) Division of Import Operations (formerly DIOP – policy has now been removed), an overview of CBP & FDA’s Joint Team 488 – which handles liquidated damages claims for underlying FDA violations and much more. Highlights of the TOP rationale for detentions follows, as I feel this is of most value to you to know and is arranged by commodity.

Food Products Top Rationales for Detention

•Manufacturer (processor, packer or person holding food product) is not registered with the FDA pursuant to the Bioterrorism Act. (You can Register with the FDA here: www.FDA-USA.com)

•Low Acid Canned Foods (LACF) are imported without establishment registration (FCE #) or scheduled process (SID #)

•The products are subject to an Import Alert

•Product labeling is not compliant (FDA does not pre-approve food labeling, it is up to importers to assure it is compliant before importing)

•Common labeling violations include:

1.Label is not in English

2.Incorrect or missing statement of identity

3.Failure to list allergens

4.Failure to declare ingredients

5.Failure to include a proper “Nutrition Facts” label (incorrect formats for Nutrition Facts labeling is also common) required by 21 C.F.R. 101.9

6.Color additives are not declared correctly (or at all) on the label or not certified

7.Food additives are unsafe or not declared on the label

Dietary Supplements Top Rationales for Detention

•The products are subject to an Import Alert

•Product labeling is not compliant (FDA does not pre-approve dietary supplement labeling, it is up to importers to assure it is compliant before importing)

•Common labeling violations include:

1. Label is not in English

2.Unauthorized health claims

3.Undeclared active ingredients

4.Lacks a “Supplement Facts” panel required by 21 C.F.R. 101.36

5.Failure to list the name of product and “Dietary Supplement” or “Herbal Supplement” on the label

6.Failure to list the appropriate disclaimer necessary when claims are made

Cosmetics Top Rationales for Detention

•The cosmetics are subject to an Import Alert (for example IA 66-38 for cosmetics labeled with drug claims)

•The cosmetics are contaminated and unsafe to use

•The cosmetics are manufactured under unsanitary conditions

•The cosmetics contain a non-permitted color additive

•Product labeling is not compliant (FDA does not pre-approve cosmetic labeling, it is up to importers to assure it is compliant before importing)

•Common labeling violations include:

1. Label is not in English

2.Labeling is missing ingredients

3.Label lacks warnings and adequate directions for use

4.Missing the net quantity of contents

5.Cosmetic contains a “drug” claim

Drugs Top Rationales for Detention

•The cosmetics are subject to an Import Alert (for example IA 66-41 – Unapproved new drugs)

•Drugs are not registered or listed with the FDA

•Product labeling is not compliant (FDA does not pre-approve drug labeling, it is up to importers to assure it is compliant before importing)

•Common labeling violations include:

1.Label is not in English

2.Label does not contain adequate directions for use

3.Active Pharmaceutical Ingredients (API) is not properly labeled or listed

4.Drug contains a “new” chemical or a different dosage making the product a “new drug”

Medical Devices Top Rationales for Detention

•The manufacturers is not registered with the FDA

•The initial importer is not registered with the FDA

•The device is not listed with the FDA

•The product does not contain a 510k or PMA

•Product labeling is not compliant (FDA does not pre-approve medical device labeling, it is up to importers to assure it is compliant before importing)

•Common labeling violations include:

1.Label is not in English

2.Label is false or misleading

Bottom line, as you can see, it is up to you, the importer to perform pre-compliance and assure you get compliance right before you import. FDA expects you to know the requirements and has little mercy if you don’t. Assure you stay compliant and avoid the top rationale for FDA to detain your goods by hiring someone that is extremely knowledgeable with FDA’s laws and regulations and continually stays up to date with the constant changes.  Contact me with any questions!

]]>
https://diaztradelaw.com/fda-discusses-top-reasons-for-detention-of-goods-2/feed/ 1 2296